In a ceremony held at the New York Public Library on June 26,2006, Microsoft founder and global health philanthropist BillGates expressed his belief that "there is no reason we can'tcure the top 20 diseases."1 To achieve this ambitious objective,however, international health organizations will need to greatlyexpand their efforts, especially in low-income countries, toprevent and treat noncommunicable chronic diseases.
Although there are many ways to classify diseases and to evaluatethe burden of disease, it is clear that by any measure, severalnoncommunicable chronic diseases have a place in the globaltop 20. For example, . . . [Full Text of this Article]
Source Information
Dr. Anderson is a professor of health policy and management at Johns Hopkins Bloomberg School of Public Health, and Mr. Chu is a medical student at Johns Hopkins School of Medicine — both in Baltimore.
This article has been cited by other articles:
Glew, R. H.
(2008). Promoting Collaborations Between Biomedical Scholars in the U.S. and Sub-Saharan Africa. Exp. Biol. Med.
233: 277-285
[Abstract][Full Text]
Touyz, R. M.
(2008). Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am. J. Physiol. Heart Circ. Physiol.
294: H1103-H1118
[Abstract][Full Text]
Anderson, G. F., Frogner, B. K., Reinhardt, U. E.
(2007). Health Spending In OECD Countries In 2004: An Update. Health Aff (Millwood)
26: 1481-1489
[Abstract][Full Text]
